The Most Common Complication Is Nausea, and After a Facelift It Is Not Minor

Ask a surgeon about complications and you will hear about hematoma, infection, seroma, and blood clots. Ask a patient what actually went wrong, and a large share will describe something that never appears on the risk list they signed: they spent the first night vomiting. Nausea after cosmetic surgery is the most common adverse outcome in elective aesthetic procedures, and it is routinely filed under discomfort rather than complication.

That filing is wrong on two counts. The first is that postoperative nausea and vomiting is largely predictable, because the risk factors have been validated for more than twenty years and the typical cosmetic patient carries most of them. The second is that in certain operations, retching is not merely unpleasant. It is a mechanical event that drives blood pressure and venous pressure up in a face that was operated on four hours earlier.

The aesthetic patient is, statistically, the worst case

The short answer: the four validated predictors of postoperative nausea describe the average cosmetic surgery patient almost exactly.

The tool that anesthesiologists use is the simplified risk score published by Christian Apfel and colleagues in Anesthesiology in 1999. It has four items: female sex, nonsmoker, a history of postoperative nausea or motion sickness, and the expected use of postoperative opioids. The reported incidence climbs roughly in steps with each factor present, from about 10 percent with none of them to around 80 percent when all four apply.

Now map that onto an aesthetic practice. The overwhelming majority of cosmetic surgery patients are women. Nearly all of them are nonsmokers on the day of surgery, because smoking cessation is a hard requirement weeks in advance. Most will receive opioids at some point in the first 24 hours. A meaningful share report motion sickness or a bad experience with a previous anesthetic. Three of four factors is the baseline in this field, not the outlier.

There is a structural reason this gets underestimated. Much of the surgical literature on nausea comes from hospital populations that include large numbers of male patients, smokers, and emergency cases. Cosmetic surgery selects for the exact demographic the risk score flags, then adds long operative times and, frequently, procedures on the head, neck, and abdomen. A practice that treats nausea prophylaxis as optional is applying general surgical averages to a population that sits well above them.

After a facelift, vomiting is a bleeding event

The short answer: hematoma is the most common significant complication of facelift surgery, and postoperative vomiting and blood pressure spikes are recognized contributors to it.

Hematoma after rhytidectomy is generally reported in the low single digits as a percentage of cases, with higher rates in men. The mechanism that turns a dry surgical field into an expanding hematoma is usually a surge in blood pressure during the first several hours after the operation, which is precisely what retching produces. A patient straining against a closed glottis generates a large, sudden rise in venous and arterial pressure in the head and neck.

This is why blood pressure control and antiemetic prophylaxis appear next to each other in facelift protocols. They are addressing the same failure mode from two directions.

The same logic extends beyond the face, in less dramatic form. Forceful vomiting loads an abdominal wall repair in the hours after a tummy tuck with a plication of the rectus muscles. It raises pressure across fresh suture lines. It also drives dehydration, which in turn produces low blood pressure, dizziness, and the sort of unsteady first walk that leads to falls. None of these are exotic. They are the ordinary downstream consequences of an event most consent forms treat as a side effect.

"

Nausea is the one complication where the patient's experience and the surgeon's risk register disagree completely. To the patient it is the defining memory of the first night. To the chart it is a checkbox that was never at issue.

"

What the guidelines say, and how often it is ignored

The short answer: modern consensus guidance recommends multiple antiemetic agents given before symptoms start for patients at moderate to high risk, rather than a single drug administered after the vomiting begins.

The reference document is the Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting, published by Tong Gan and colleagues in Anesthesia and Analgesia in 2020, developed with input from the Society for Ambulatory Anesthesia. Its central shift from earlier versions is a move away from using risk scores as gatekeepers. The guidance leans toward liberal multimodal prophylaxis, because the drugs are inexpensive, the side effect profile is mild, and the calculus in an elective ambulatory population favors preventing the event.

The components are unglamorous and well established:

• Dexamethasone, a steroid given at induction, which has an antiemetic effect alongside its effect on swelling.
• Ondansetron or a related serotonin antagonist, typically given toward the end of the operation.
• Transdermal scopolamine, a patch applied before surgery for a longer window of coverage.
• Aprepitant, a longer-acting agent that has been studied specifically in plastic surgery populations where delayed nausea at home is the concern.
• Total intravenous anesthesia using propofol instead of inhaled volatile agents, which reduces nausea enough that anesthesiologists often describe it as roughly equivalent to adding an antiemetic.
• Opioid reduction, since opioid exposure is one of the four Apfel predictors and one the surgical team controls directly.

That last item connects nausea prophylaxis to a change already underway for other reasons. The move toward opioid-sparing recovery protocols using regional blocks, local anesthetic infiltration, acetaminophen, and anti-inflammatories was driven by the addiction literature. Its effect on nausea is a second dividend, and it is a large one.

The variables patients control, and the ones they do not

The short answer: hydration, honest disclosure, and the drive home matter more than most patients expect, and one increasingly common medication class has changed the fasting conversation entirely.

Prolonged fasting is the most common self-inflicted contributor. Patients told nothing by mouth after midnight often arrive dehydrated after fourteen or more hours without fluid, which worsens nausea and low blood pressure. Modern enhanced recovery protocols permit clear liquids up to about two hours before anesthesia in most patients, and many practices allow a carbohydrate drink. If a patient is being told to fast from midnight for an afternoon case, that is worth a question.

The exception now sits with GLP-1 medications. Because these drugs slow gastric emptying, professional anesthesia guidance has addressed whether patients on them require adjusted fasting instructions or should hold doses before surgery. That is a real consideration in an aesthetic practice, where a large share of body contouring patients are arriving on exactly these medications, and it belongs in the same conversation as their broader perioperative implications.

Two other practical items get missed. The first is the car ride. Motion after an anesthetic is a genuine trigger, and a long drive home from a surgical center is a bad first hour for a susceptible patient. The second is the anti-nausea prescription itself: it needs to be filled and physically present before the patient leaves, not phoned to a pharmacy at midnight by a caregiver who has to leave the patient alone to collect it. This is the kind of item that a well-run aftercare plan handles and a thin one does not, and it is worth asking about alongside what the surgical quote does and does not include.

What a competent practice does differently

The short answer: it has a written protocol that applies to every patient, and the anesthesia provider is part of the conversation before the day of surgery.

The tell is whether prophylaxis is standardized or improvised. A practice with a protocol can describe it: which agents, at what point in the case, what the default anesthetic technique is, and what changes for a patient with a history of severe nausea. A practice without one will describe intentions.

This is also a reason the identity and involvement of the anesthesia provider matters. The choice of anesthetic technique is part of the operative plan rather than a service purchased separately on the morning of surgery. In an accredited facility, the antiemetic protocol is documented and auditable, which is one more argument for asking about facility accreditation rather than assuming it.

The honest summary

Postoperative nausea is the complication most cosmetic surgery patients will actually encounter, and the aesthetic population carries a risk profile near the top of the validated scale. The prediction tools have existed since 1999. The consensus guidance recommending layered prophylaxis has been in its fourth edition since 2020. The drugs involved are inexpensive and old.

Given that, a first night spent vomiting is usually not bad luck. It is a plan that treated a predictable, preventable event as a comfort issue, and in facelift surgery specifically, it is a plan that ignored a recognized contributor to the field's most common significant complication.

What patients should do with this is small and concrete. Disclose your history of motion sickness and previous anesthetic reactions without being asked twice. Ask what you will receive before the operation, not what you can have if things go badly. Ask whether the anesthetic is intravenous or inhaled and why. Confirm the pain plan is not opioid-heavy by default. Leave with the anti-nausea medication in your bag rather than a prescription on your phone.

A practice that has ready answers to all five has thought about the twelve hours after you leave the building. That is a reasonable proxy for how it thinks about everything else you cannot see.